Hemopexin ELISA Assay for Nitrated Protein Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to accurately detect levels of nitrated hemopexin in biological fluids, leading to underestimation of active hemopexin levels and inadequate diagnosis and treatment of conditions like sepsis and sickle cell disease, where hemopexin deficiency is critical.
Innovation Solution
A two-site sandwich enzyme-linked immunosorbent assay (ELISA) is developed to detect both nitrated and non-nitrated hemopexin in serum, plasma, and cerebral spinal fluid, providing a sensitive and accurate measurement of active hemopexin levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard techniques are used to measure total hemopexin levels, then the measurement is simple and quick, but the measurement precision is insufficient because nitrated hemopexin cannot be distinguished from active hemopexin
Solution Approach 1:
The assay is divided into two separate measurement components: a total hemopexin assay and a nitrated hemopexin assay. By segmenting the measurement into distinct assays that target different forms of hemopexin, the system achieves precise differentiation between active and inactivated hemopexin while maintaining operational simplicity through standardized ELISA procedures
Solution Approach 2:
Nitrotyrosine-specific antibodies are introduced as intermediary detection tools that selectively bind to nitrated hemopexin. This intermediary mechanism enables the differentiation of nitrated forms from total hemopexin, providing measurement precision without requiring complex analytical instrumentation
2Reliability
If current methods are used to assess hemopexin levels, then the diagnostic process is fast, but the reliability is insufficient due to underestimation of active hemopexin
Solution Approach 1:
The methodology performs preliminary differentiation between nitrated and total hemopexin through separate ELISA assays before clinical decision-making. This preliminary action ensures reliable assessment of active hemopexin levels, preventing misdiagnosis and inappropriate treatment while maintaining efficient workflow through parallel assay execution
3Measurement precision
If a single assay measures total hemopexin, then the ease of operation is high, but the measurement precision deteriorates because nitrated hemopexin is included in the measurement
Solution Approach 1:
The measurement system is segmented into two distinct ELISA assays: one for total hemopexin and another for nitrated hemopexin. Each assay is optimized for its specific target, achieving high measurement precision while maintaining ease of operation through standardized, well-established ELISA protocols that are familiar to laboratory personnel
Solution Approach 2:
Each ELISA assay is designed with local quality optimization: the total hemopexin assay uses antibodies that recognize all hemopexin forms, while the nitrated hemopexin assay uses nitrotyrosine-specific antibodies for selective detection. This localized optimization ensures precise measurement of each specific target without compromising operational simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ELISA assay enables early diagnosis of hemopexin deficiency states, allowing for timely administration of hemopexin infusions and improving clinical outcomes in conditions such as sepsis and sickle cell disease by accurately assessing the risk of heme toxicity.
Implementation Method 1
A two-site sandwich enzyme-linked immunosorbent assay (ELISA) is developed to detect both nitrated and non-nitrated hemopexin in serum, plasma, and cerebral spinal fluid
Data Source
AI summary
A method of detecting and measuring the level of total hemopexin and nitrated hemopexin in a sample of a patient in need thereof. The method uses an ELISA for total and nitrated hemopexin.